Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary biliary cirrhosis: current knowledge, perspectives, and future directions.

I R Mackay1, M E Gershwin

  • 1Centre for Molecular Biology and Medicine, Monash University, Clayton, Victoria, Australia.

Seminars in Liver Disease
|May 1, 1989
PubMed
Summary

Primary Biliary Cirrhosis (PBC) research focuses on autoimmune aspects, including M2 autoantigens like pyruvate dehydrogenase. Further study is needed on T-cell roles and clinical subsets for better treatment and transplantation timing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes.

Autoimmunity·2003
Same author

Humanism and the suffering of the people.

Internal medicine journal·2003
Same author

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same author

A dietary cause of type 1 diabetes: unearthing a new twist to the tale.

Diabetes technology & therapeutics·2002
Same author

Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.

Journal of gastroenterology and hepatology·2002
Same author

Dietary microbial toxins and type 1 diabetes--a new meaning for seed and soil.

Diabetologia·2001

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Primary Biliary Cirrhosis (PBC) is an autoimmune liver disease with complex pathogenesis.
  • M2 autoantigens, identified as mitochondrial 2-oxo-acid dehydrogenase enzymes, are key targets in PBC.
  • Associated autoimmune diseases and clinical heterogeneity require further investigation.

Purpose of the Study:

  • To review recent advances in Primary Biliary Cirrhosis research.
  • To identify areas for future investigation, including autoimmune associations, clinical subsets, and pathogenesis.
  • To explore the role of mitochondrial autoantigens and T-cell responses in PBC.

Main Methods:

  • Review of current literature and symposium perspectives.
  • Identification and characterization of M2 autoantigens (e.g., pyruvate dehydrogenase).

Related Experiment Videos

  • Discussion of potential T-cell epitope mapping and analysis of lymphoid infiltrates.

    • Main Results:

    • M2 autoantigens are mitochondrial 2-oxo-acid dehydrogenase enzymes, including pyruvate dehydrogenase.
    • An autoepitope on pyruvate dehydrogenase has been identified.
    • Questions remain regarding the precise role of antibodies to these enzymes and T-cell contributions.

    Conclusions:

    • Further research is essential to understand the full spectrum of autoimmune responses in PBC.
    • Investigating T-cell contributions and identifying clinical subsets may improve treatment strategies and liver transplantation outcomes.
    • Clarifying the significance of various autoantibodies is crucial for PBC diagnosis and management.